期刊文献+

凋亡相关因子与卵巢肿瘤研究进展 被引量:2

Progression of apoptosis related factors and ovarian tumor
下载PDF
导出
摘要 细胞凋亡又称程序性细胞死亡 ,其在卵巢肿瘤中起着举足轻重的作用。研究发现 ,凋亡相关因子的调控失衡直接导致卵巢肿瘤的发生发展 ,影响肿瘤的预后和治疗。现详述几类重要的凋亡相关因子与卵巢肿瘤的最新研究动态。
出处 《国外医学(肿瘤学分册)》 2004年第9期709-713,共5页 Foreign Medical Sciences (Cancer Section)
  • 相关文献

参考文献1

二级参考文献9

  • 1NicAmhlaoibh R, Heenan M, Cleary I, et al.Altered expression of mRNAs for apoptosis-modulating proteins in a low level multidrug resistant variant of a human lung carcinoma cell line that also expresses mdr1 mRNA.Int J Cancer, 1999,82:368-376.
  • 2Sambrook J, Fritsch EF, Maniatis T.分子克隆.金冬雁,黎孟枫,译.第2版.北京:科学出版社,1996.889-890.
  • 3Khachigian LM, Williams AJ, Collins T.Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells.J Biol Chem, 1995,270:27679-27686.
  • 4Liu JR, Fletcher B, Page C, et al.Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.Gynecol Oncol, 1998,70:398-403.
  • 5Rogers PM, Beale PJ, Al-Moundhri M, et al.Overexpression of bcl-XL in a human ovarian carcinoma cell line: paradoxic effects on chemosensitivity in vitro versus in vivo.Int J Cancer, 2002,97:858-863.
  • 6Ohi Y, Kim R, Toge T.Overcoming of multidrug resistance by introducing the apoptosis gene, bcl-Xs, into MRP-overexpressing drug resistant cells.Int J Oncol, 2000,16:959-969.
  • 7Kojima H, Endo K, Moriyama H, et al.Abrogation of mitochondrial cytochrome c release and caspase-3 activation in acquired multidrug resistance.J Biol Chem, 1998,273:16647-16650.
  • 8Asselin E, Mills GB, Tsang BK.XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.Cancer Res, 2001,61:1862-1868.
  • 9杨晓葵,郑芳,邢辉,高庆蕾,王薇,卢运萍,王世宣,马丁.细胞色素c介导的半胱天冬氨酸蛋白酶-3活性改变与人卵巢癌顺铂耐药的关系[J].中华肿瘤杂志,2002,24(6):544-547. 被引量:12

共引文献6

同被引文献19

  • 1萨姆布鲁克J 金冬雁译.分子克隆实验指南[M].北京:科学出版社,1998.55-56.
  • 2迪芬巴赫CW 德维克斯勒GS 等.PCR技术实验指南[M].北京:科学出版社,1999..
  • 3Dotti G, Savoldo B, Yotnda P, et al. Transgenic expression of CD40 ligand produces an in vivo antitumor immunere sponse against both CD40+ and CD40- plasmacytoma cells[J]. Blood, 2002, 100(1) : 200 -207.
  • 4Caux C, Massacrier C, Vanbervlier B, et al. Activation of human dendritic cells through CD40 cross -linking[ J]. J Exp Med, 1994, 180(4): 1263-1272.
  • 5Ciaravino G, Bhat M, Manbeian CA, et al. Differential expression of CD40 and CD95 in ovarian carcinoma [ J ].Eur J Gynaecol Oncol, 2004, 25 ( 1 ) : 27 - 32.
  • 6Schlienger K, Chu CS, Woo EY, et al. TRANCE - and CD40 ligand -matured dendritic cells reveal MHC class Ⅰ- restricted T cells specific for autologous tumor in late -stage ovarian cancer patients[ J]. Clin Cancer Res, 2003,9(4) : 1517 - 1527.
  • 7von l.eoprechting A, vonder Bruggen P, Pahl HL, et al.Stimulation of CD40 on immunogenic human malignant melanomas augments their cytotoxic T lymphocyte - mediated lysis and induces apoptosis [ J ]. Cancer Res, 1999,59(6) : 1287 - 1294.
  • 8Lu LF, Cook W J, Lin LL, et al. CD40 signaling through a newly identified tumor necrosis factor receptor - associated factor 2 ( TRAF2 ) binding site [ J ]. J Biol Chem,2003, 278(46) : 45414 -45418.
  • 9Hostager BS, Haxhinasto SA, Rowland SL, et al. Tumor necrosis factor receptor - associated factor 2 ( TRAF2 ) -deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling [ J ]. J Biol Chem, 2003, 278 ( 46 ) :45382 - 45390.
  • 10Li C, Ni CZ, Havert ML, et al. Downstream regulator TANK binds to the CD40 recognition site on TRAF3 [ J ].Structure, 2002, 10(3) : 403 -411.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部